Enteric infections and diagnostic testing.

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri 63110, USA.
Current opinion in gastroenterology (Impact Factor: 3.66). 02/2009; 25(1):1-7. DOI: 10.1097/MOG.0b013e32831ba094
Source: PubMed

ABSTRACT Gastrointestinal pathogens profoundly affect human health and well being. The provider's ability to render optimal care often highly depends on diagnostic microbiologic support. We aim to provide a clinically pertinent assessment of the current state of our ability to diagnose human gastrointestinal pathogens and describe (and decry) the unsophistication of many current diagnostic methods and strategies.
Recent advances involve improved stool polymerase chain reaction assays and application of this technology to a broader panel of pathogens, stool antigen assays, and improved culture techniques, but there is little penetration of such diagnostic advances into clinical practice. Many such techniques remain limited to research or epidemiologic use and are not typically available in the clinical laboratory.
Multiple clinical and laboratory factors need to be considered when attempting to diagnose the wide variety of gastrointestinal pathogens afflicting humans. Careful interpretation of diagnostic tests with attention to the population studied and the characteristics of each test is necessary.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Shiga toxin-producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt laboratory identification of STEC strains is essential for detecting new and emerging serotypes, for effective and timely outbreak responses and control measures, for monitoring trends in disease epidemiology, and to ensure accurate diagnosis and treatment. Guidelines for laboratory identification of STEC infections by clinical laboratories were published in 2006 and 2009 (CDC, MMWR Morb. Mortal. Wkly. Rep. 55:1042-1045, 2006; MMWR Recomm. Rep. 58[RR-12], 1–14, 2009). We summarize these recent recommendations for STEC testing by clinical laboratories to emphasize the recommendation that all stools submitted for routine testing from patients with acute community-acquired diarrhea (regardless of patient age, season of the year, or presence or absence of blood in the stool) be simultaneously cultured for E. coli O157:H7 (O157 STEC) and tested with an assay that detects Shiga toxins to detect non-O157 STEC.
    Clinical Microbiology Newsletter 05/2012; 34(10):75–83. DOI:10.1016/j.clinmicnews.2012.04.004
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gastroenteritis persists as a worldwide problem, responsible for approximately 2 million deaths annually. Traditional diagnostic methods used in the clinical microbiology laboratory include a myriad of tests, such as culture, microscopy, and immunodiagnostics, which can be labor intensive and suffer from long turnaround times and, in some cases, poor and Yi-Wei Tang sensitivity. This article reviews recent advances in genomic and proteomic technologies that have been applied to the detection and identification of gastrointestinal pathogens. These methods simplify and speed up the detection of pathogenic microorganisms, and their implementation in the clinical microbiology laboratory has potential to revolutionize the diagnosis of gastroenteritis.
    Clinics in laboratory medicine 09/2013; 33(3):527-52. DOI:10.1016/j.cll.2013.03.003 · 1.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Enterohemorrhagic Escherichia coli (EHEC) strains can cause hemolytic uremic syndrome (HUS), a leading cause of childhood renal failure. The adhesin intimin and the secreted proteins A (EspA) and B (EspB) contribute to the occurrence of EHEC attaching and effacing lesions. In this study, immunoblot assays were performed to determine immunoglobulin G (IgG) antibodies reactive with these proteins in sera from 13 children diagnosed with HUS and in sera from 54 healthy Brazilian children. In general, high frequencies of serum IgG antibodies reactive with EspA, EspB and the conserved region of intimin were observed in both HUS patients and controls with no statistically significant differences. However, a marked difference in immune response to these proteins was observed in HUS patients compared to controls in infants less than two years of age. In addition, IgG against the variable region of intimin γ was more frequently detected in HUS patients than in children with no signs of infection (p<0.05) regardless of age, suggesting that the detection of antibodies directed to the variable region of intimin γ can be useful in serodiagnostic tests of EHEC-infected patients. The immune response against intimin and structural proteins encoded by the locus of enterocyte effacement pathogenicity island in patients with HUS has previously not been described in Brazil. The results presented here may contribute to the development of diagnostic tools and complement information concerning EHEC epidemiology in our setting.
    Veterinary Immunology and Immunopathology 09/2012; 152(1-2). DOI:10.1016/j.vetimm.2012.09.016 · 1.75 Impact Factor